Illumina Inc.

Gene expression profiling using microarray technology

Illumina was founded in April 1998 by John Stuelpnagel and Mark Cheek. The company’s core technology was developed by Stuelpnagel at Tufts University.

In April 2005, Illumina announced the acquisition of Cyvera Corporation whose microbead assay technology platform provides a robust detection method for many applications.

Jay Flatley (President and CEO)
David L. Barker, Ph.D. (Vice President and Chief Scientific Officer)
Paulette Cabral (Vice President of Human Resources)
David C. Douglas (Vice President of Manufacturing)
Christian Henry (Vice President and Chief Financial Officer)
Scott Kahn, Ph.D. (Chief Information Officer)
John Stuelpnagel, DVM (Chief Operating Officer)

9885 Towne Centre Drive
San Diego, CA 92121-1975
USA
Phone: +1-858-202-4500
Fax: +1-858-202-4545

Illumina is offering products for genotyping and gene expression profiling, including Oligator® oligonucleotide manufacturing and BeadArray™ platform technologies.

BeadArray™ technology supports SNP genotyping, gene expression profiling and proteomics and includes the microarray platforms Sentrix® Array Matrix and the Sentrix BeadChip. The Sentrix BeadChips are designed for low to medium sample throughput or dense whole-genome applications.